Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to TrastuzumabVincenzo Quagliariello, Nicola Maurea, Margherita Passariello et al.|International Journal of Cardiology|2019Cited by 64
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patientsStefano Cascinu, Rossana Berardi, Gerardo Rosati et al.|European Journal of Cancer|2017Cited by 30
SARS-CoV-2 infection: NLRP3 inflammasome as plausible target to prevent cardiopulmonary complications?Vincenzo Quagliariello, Nicola Maurea, Annamaria Bonelli et al.|PubMed|2020Cited by 25
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trialGerardo Rosati, Giordano Beretta, Sara Lonardi et al.|European Journal of Cancer|2021Cited by 15
Reasons why COVID-19 survivors should follow dietary World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) recommendations: from hyper-inflammation to cardiac dysfunctionsVincenzo Quagliariello, Nicola Maurea, Giuseppe D’Aiuto et al.|PubMed|2021Cited by 10